PTC Therapeutics (NASDAQ:PTCT) Shares Gap Down After Analyst Downgrade

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) gapped down prior to trading on Friday after Cantor Fitzgerald lowered their price target on the stock from $51.00 to $45.00. The stock had previously closed at $26.66, but opened at $25.71. Cantor Fitzgerald currently has an overweight rating on the stock. PTC Therapeutics shares […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Allan Steven Jacobson ,Barclays ,Wells Fargo Company ,Armistice Capital ,Cantor Fitzgerald ,Morgan Stanley ,Wellington Management Group ,Nasdaq ,Norges Bank ,Therapeutics Inc ,Get Free Report ,Director Allan Steven Jacobson ,Marie Utter ,Management Group ,State Street Corp ,Street Corp ,Ptc Therapeutics ,Nasdaq Ptct ,Ptct ,Medical ,Stocks ,Technicals ,